News Sentiment

XGN sentiment intelligence

Exagen Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 51 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 4.45 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

76/100 classification confidence.

Company focus 51

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-2.0% over one week, -4.7% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

ETFs Investing in Exagen, Inc. Stocks

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 76/100 classification
One-week reaction -2.0% Price reacting lower
Trend fit Trend inactive -4.7% over four weeks
Fair value 6.8% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 32
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 51
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingView 12
TradingKey 7
Market source 5
Stock Titan 4
GuruFocus 2
MarketBeat 2
simplywall.st 2
AD HOC NEWS 1

Event Lens

What the news is about

Classified themes
Market update 23
Earnings 17
Analyst action 8
Balance sheet 1
Regulatory and legal 1
Capital return 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-51 of 51
TradingKey Direct company coverage

Exagen Inc (XGN) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Exagen Inc (XGN), detailing its price momentum, support and resistance levels, and various technical indicators like MACD, RSI, and moving averages. The stock currently has a price momentum score of 8.90, trading between resistance at

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 10:10
Source
TradingKey
TradingKey Direct company coverage

Exagen Inc (XGN) Institutional Confidence

Exagen Inc (XGN) has an institutional shareholding score of 5.00, placing it 49th out of 76 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 58.04%, marking a 7.71% quarter-over-quarter decrease. James Simons is the largest inst

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 10:10
Source
TradingKey
TradingKey Direct company coverage

Exagen Inc (XGN) Earnings Forecast: Future EPS & Revenue Growth Estimates

Exagen Inc (XGN) has an earnings forecast score of 8.57, ranking 10th in the Healthcare Providers & Services industry, with an average analyst price target of $15.00. Based on 7 analysts, the stock currently holds a "Buy" rating. The company's expected revenue for the next quarte

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 10:10
Source
TradingKey
The Globe and Mail Direct company coverage

Exagen Shareholders Approve Directors, Auditor and Pay Package

Exagen Inc. held its 2026 annual meeting where shareholders re-elected two Class I directors, Tina S. Nova and Scott Kahn, to three-year terms. They also ratified BDO USA, P.C. as the independent auditor and approved the compensation for named executive officers, indicating stron

Tone
Positive 66/100
Event
Market update
Published
11 Jun 2026 12:08
Source
The Globe and Mail